NORMAL SITUATION

VEXO

Export PDF

Financial year 2023 · closed on 29/09/2023

Net result

8,3 k €

-98.3% YoY

Gross margin

3,6 k €

-99.3% YoY

Equity

646,7 k €

+1.3% YoY

Company — Normal situation.

What does VEXO do?

VEXO is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0874.668.992

Legal form

Private limited company

Contributed capital

40 000,00 €

Latest accounts

29/09/2023

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	3,6 k €	-99.3%	487,7 k €	+4353%	11 k €	-21.7%	14 k €	-86.0%	99,8 k €	-62.4%	265,2 k €	+8.3%	244,8 k €	+14.4%	213,9 k €	+46.1%	146,5 k €	+16.9%	125,4 k €	+27.5%	98,3 k €	+28.2%	76,7 k €	+53.2%	50,1 k €	+40.3%	35,7 k €	+704%	4,4 k €	+454%	-1,3 k €	+95.5%	-27,6 k €	+62.7%	-73,9 k €
EBITDA	3,6 k €	-99.3%	487,1 k €	+6774%	7,1 k €	-41.2%	12 k €	+358%	-4,7 k €	-105%	100,1 k €	-7.7%	108,5 k €	+22.4%	88,6 k €	+260%	24,6 k €	-59.9%	61,4 k €	+35.9%	45,2 k €	-5.1%	47,6 k €	+2.8%	46,3 k €	+42.9%	32,4 k €	+668%	4,2 k €	+378%	-1,5 k €	+94.6%	-28 k €	+62.3%	-74,3 k €
Operating result	3,6 k €	-99.3%	485,1 k €	+10424%	4,6 k €	-41.2%	7,8 k €	+176%	-10,3 k €	-111%	94,4 k €	-4.5%	98,8 k €	+22.9%	80,4 k €	+375%	16,9 k €	-71.2%	58,7 k €	+36.7%	43 k €	+0.2%	42,9 k €	+15.2%	37,3 k €	+20.4%	30,9 k €	+700%	3,9 k €	+290%	-2 k €	+93.2%	-29,8 k €	+61.6%	-77,5 k €
Net result	8,3 k €	-98.3%	493,3 k €	+25569%	1,9 k €	-70.4%	6,5 k €	+140%	-16,4 k €	-127%	61,7 k €	+5.4%	58,5 k €	+4.8%	55,8 k €	+1451%	3,6 k €	-90.4%	37,4 k €	+34.1%	27,9 k €	+1.4%	27,5 k €	-22.5%	35,5 k €	+33.5%	26,6 k €	+1588%	-1,8 k €	+79.9%	-8,9 k €	+74.7%	-35,1 k €	+57.5%	-82,4 k €
Balance sheet
Equity	646,7 k €	+1.3%	638,4 k €	+340%	145,1 k €	-13.4%	167,5 k €	+4.0%	161 k €	-9.2%	177,4 k €	+47.5%	120,3 k €	-27.7%	166,3 k €	+32.6%	125,4 k €	+3.0%	121,8 k €	+22.6%	99,4 k €	+15.0%	86,4 k €	+17.0%	73,9 k €	+92.4%	38,4 k €	+225%	11,8 k €	+115%	-76,4 k €	-13.2%	-67,5 k €	-108%	-32,4 k €
Total assets	650,6 k €	-6.6%	696,7 k €	+306%	171,6 k €	-0.9%	173,1 k €	+3.7%	166,9 k €	-39.6%	276,1 k €	+9.5%	252,1 k €	-15.0%	296,4 k €	+30.7%	226,8 k €	-2.8%	233,4 k €	+38.5%	168,5 k €	+0.6%	167,5 k €	+23.1%	136 k €	+50.6%	90,3 k €	+55.9%	57,9 k €	+76.4%	32,8 k €	-29.1%	46,3 k €	-13.6%	53,6 k €
Cash	41,2 k €	-54.5%	90,6 k €		–		138,2 k €	+225%	42,5 k €	-74.0%	163,2 k €	+28.1%	127,4 k €	-28.2%	177,3 k €	+94.7%	91,1 k €	-17.7%	110,7 k €	+35.5%	81,7 k €	-9.4%	90,2 k €	+90.1%	47,4 k €	+33.4%	35,6 k €	+37.6%	25,9 k €	+4234%	596,5 €	-64.8%	1,7 k €	+3225%	51 €
Debts	3,8 k €	-93.4%	58 k €	+119%	26,5 k €	+371%	5,6 k €	-4.0%	5,9 k €	-94.0%	98,3 k €	-23.8%	129 k €	+2.6%	125,8 k €	+24.1%	101,4 k €	-9.1%	111,5 k €	+61.4%	69,1 k €	-14.7%	81 k €	+30.4%	62,2 k €	+20.5%	51,6 k €	+14.0%	45,2 k €	-58.6%	109,2 k €	-4.0%	113,8 k €	+32.3%	86 k €
Other
Workforce	–		–		–		–		1,8 ETP	-40.0%	3,0 ETP	+25.0%	2,4 ETP	+4.3%	2,3 ETP	-4.2%	2,4 ETP	+100%	1,2 ETP	+20.0%	1,0 ETP	+42.9%	0,7 ETP		–		–		–		–		–		–

Governance

Board of directors

Seen on filing of 29/09/2023 · 2 active · 9 ended

Active mandates

PHARMUNY

Director · 0443.874.077

Represented by BENOIT DESCHAMPS

Active

RENE HUSTACHE

Director

Active

Ended mandates

ANGELIQUE FONTAINE

Director

Ended

ANGELIQUE FONTAINE

Manager

Ended

PHARMUNY

Manager · 0443.874.077

Represented by BENOIT DESCHAMPS

Ended

PHARMUNY

Director · 0443.874.077

Represented by BENOIT DESCHAMPS

Ended

Annual accounts

Full financial information

	2023	2022	2021	2020	2019	2018
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018
Closing of the financial year	29/09/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018
Length of the financial year	9 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/11/2023	30/06/2023	15/06/2022	02/06/2021	22/06/2020	18/07/2019
General meeting	25/10/2023	12/05/2023	28/05/2022	08/05/2021	30/05/2020	25/05/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	29/09/2023	25/10/2023	17/11/2023	French	PDF
Micro model	31/12/2022	12/05/2023	30/06/2023	French	PDF
Micro model	31/12/2021	28/05/2022	15/06/2022	French	PDF
Abridged model	31/12/2020	08/05/2021	02/06/2021	French	PDF
Abridged model	31/12/2019	30/05/2020	22/06/2020	French	PDF
Abridged model	31/12/2018	25/05/2019	18/07/2019	French	PDF
Abridged model	31/12/2017	26/05/2018	08/06/2018	French	PDF
Abridged model	31/12/2016	03/06/2017	09/06/2017	French	PDF
Abridged model	31/12/2015	07/05/2016	23/06/2016	French	PDF
Abridged model	31/12/2014	23/05/2015	28/05/2015	French	PDF
Abridged model	31/12/2013	11/05/2014	20/06/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	05/07/2013	French	PDF
Abridged model	31/12/2011	27/05/2012	08/06/2012	French	PDF
Abridged model	31/12/2010	29/05/2011	01/06/2011	French	PDF
Abridged model	31/12/2009	03/05/2010	05/07/2010	French	PDF
Abridged model	31/12/2008	02/06/2009	19/06/2009	French	PDF
Abridged model	31/12/2007	02/06/2008	24/06/2008	French	PDF
Abridged model	31/12/2006	31/05/2007	11/06/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 29/09/2023 · 2 active · 9 ended

Active mandates

PHARMUNY

Director · 0443.874.077

Represented by BENOIT DESCHAMPS

Active

RENE HUSTACHE

Director

Active

Ended mandates

ANGELIQUE FONTAINE

Director

Ended

ANGELIQUE FONTAINE

Manager

Ended

PHARMUNY

Manager · 0443.874.077

Represented by BENOIT DESCHAMPS

Ended

PHARMUNY

Director · 0443.874.077

Represented by BENOIT DESCHAMPS

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2023
Annual accounts 20238,3 k €↓
2023
Name changeVEXO EN LIQUIDATION
2022
Annual accounts 2022493,3 k €↑
2021
Annual accounts 20211,9 k €↓
2021
Name changeVEXO
2020
Annual accounts 20206,5 k €↑
2019
Annual accounts 2019-16,4 k €↓
2018
Annual accounts 201861,7 k €↑
2017
Annual accounts 201758,5 k €↑
2016
Annual accounts 201655,8 k €↑
2015
Annual accounts 20153,6 k €↓
2014
Annual accounts 201437,4 k €↑
2013
Annual accounts 201327,9 k €↑
2012
Annual accounts 201227,5 k €↓
2011
Annual accounts 201135,5 k €↑
2010
Annual accounts 201026,6 k €↑
2009
Annual accounts 2009-1,8 k €↑
2008
Annual accounts 2008-8,9 k €↑
2007
Annual accounts 2007-35,1 k €↑
2006
Annual accounts 2006-82,4 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

VEXO

Overview

What does VEXO do?

Trend over 18 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline